PIII in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with PIII today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Health plans pay P3 Health Partners to manage care for Medicare Advantage members assigned to its primary care physicians. These monthly payments account for nearly all its revenue and are typically a negotiated share of the Medicare premiums the plans receive from the federal government. P3 takes responsibility for a defined range of medical costs, including hospital care, specialist visits and prescriptions. Its economics depend on keeping those costs within the payments it receives, rather than simply delivering more services.
P3 builds its network mainly by contracting with independent community physicians, rather than buying practices or staffing its own clinics. Physicians retain their independence and share in savings from improving care and reducing costs. P3 supplies care teams and tools, including P3 Technology/Health Hub, which combines clinical and claims data to identify patients’ needs and guide care. Accurate documentation of members’ health conditions also affects reimbursement.
Most revenue comes from a small group of health-plan contracts; important partners include Centene and UnitedHealthcare. The business depends on those relationships, the members plans assign to its network and Medicare payment rules. State laws limit how P3 can structure physician relationships and assume medical-cost risk, including licensing and capital requirements. P3 also depends on additional funding to sustain operations, and management has identified substantial doubt about its ability to continue as a going concern.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
P3’s results hinge on Medicare Advantage reimbursement and medical-cost control, while agilon health and privately held Aledade also compete for physician and payer relationships.
Astrana Health and P3 compete for physicians and health-plan contracts through networks paid monthly per member to arrange care and bear medical-cost risk. Watch Astrana’s Care Partners network partnerships, where it brings independent providers into organizations that take responsibility for care costs.
Humana pays P3 monthly per member to manage care, so Medicare Advantage funding and patients’ use of medical services affect both P3 and Humana’s Medicare insurance and senior-care businesses. Watch Humana’s Medicare plan reimbursement and medical-cost news: P3’s fees are tied to the premiums health plans receive from CMS, while P3 bears members’ care costs.
Privia Health Group competes with P3 to bring independent physicians into networks that negotiate with health insurers and support care that rewards better outcomes and lower costs. Watch Privia’s physician recruitment into regional Medical Groups, where doctors retain substantial autonomy and gain access to these payment arrangements.
Centene pays P3 monthly per member to manage care, linking P3’s revenue to a customer whose Medicare insurance business also faces Medicare Advantage funding and medical-cost pressures. Watch Centene’s Medicare plan exits or changes in care-provider arrangements, which could put P3’s contracts and revenue at risk.
InnovAge and P3 both receive monthly payments to manage older adults’ care and bear the resulting medical costs, but InnovAge contracts directly with government payers through PACE rather than P3’s Medicare Advantage networks. Its costs for all-inclusive home- and center-based senior care offer a comparison for the cost pressures P3 faces, not a direct read on P3’s Medicare Advantage reimbursement.
Centene Corporation earningsCNC
Centene’s report will show whether its Medicare Advantage plans and care arrangements remain stable, which affects P3’s ability to keep earning per-member fees from this customer.
Watch whether Centene exits Medicare Advantage plans or changes its care-provider arrangements. Stable plans and arrangements would support P3’s existing customer relationship; exits or changes would put the related contracts and member revenue at risk.
Fed Interest Rate Decision
P3 Health Partners’ Fed rate backdrop matters because it carries high-rate debt and must refinance or repay it, so higher borrowing costs can leave less cash for medical claims and care operations.
Expected4.0%Last release4.0%
If it comes in above expectations
If the Fed rate is above the estimate, P3 Health Partners may face costlier new or refinanced borrowing, leaving less cash to meet claims and fund care while adding pressure to liquidity.
If it comes in below expectations
If the Fed rate is below the estimate, P3 Health Partners may be able to borrow or refinance more cheaply, easing debt-service pressure and leaving more cash for claims and care.
Astrana Health Inc. earningsASTH
Astrana Health’s report will show whether its Care Partners network is bringing independent physicians on board, a sign of the competition P3 faces for doctors and health-plan contracts.
Look for growth in Care Partners network partnerships and read it alongside physician recruitment. More partners would suggest physicians remain willing to join organizations that take responsibility for care costs, intensifying P3’s competition for the same doctors and health plans. Fewer partners or slower expansion could ease that competition, but may also signal limited physician appetite for these arrangements.
Humana Inc. earningsHUM
Humana’s report will show how Medicare Advantage premiums and medical costs are changing, affecting the per-member fees it pays P3 and the care costs P3 bears.
Read Humana’s Medicare Advantage revenue and medical-cost trends together. Steadier revenue with controlled costs would suggest its plan economics can better support the per-member fees paid to P3. Revenue pressure or rising medical costs could squeeze the health plan, while P3 still bears its members’ care costs.
P3 Health Partners Inc. earningsThis company
P3 collects monthly per-member fees and bears members’ medical costs, so this report will show whether member losses and care costs are still squeezing the business.
Read at-risk membership, capitated revenue and medical expenses together. Stabilizing membership and revenue growing faster than medical expenses would suggest P3 is retaining enough paying members and that care costs remain covered by the fees. Further membership losses, or medical expenses growing faster than revenue, would mean continued pressure from taking on members’ care costs and potentially greater funding needs.